Cel Sci Corporation (CVM)

[exwannabe]

And this is all for a drug with a median extended life expectancy of more than 4 years and zero toxicity!!

In the overall trial the median was not extended at all.

In the subgroup you can be proud of that 101.7 months mOS driven by a single patient,

How about we look at the subgroup after that one patient died?

OS at 102 months in the low risk patients:
Multikine:: 0%
Placebo: 40%

The wonderful world of cherry-picking sub-sets and thin data.